Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report researches the worldwide Eculizumab market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global Eculizumab breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Eculizumab market report explains the definition, types, applications, major countries, and major players of the Eculizumab market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Alexion
By Type:
Plasma Exchange
Plasma Infusion
By End-User:
PNH
aHUS
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Eculizumab Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Eculizumab Outlook to 2028- Original Forecasts
-
2.2 Eculizumab Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Eculizumab Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Eculizumab Market- Recent Developments
-
6.1 Eculizumab Market News and Developments
-
6.2 Eculizumab Market Deals Landscape
7 Eculizumab Raw Materials and Cost Structure Analysis
-
7.1 Eculizumab Key Raw Materials
-
7.2 Eculizumab Price Trend of Key Raw Materials
-
7.3 Eculizumab Key Suppliers of Raw Materials
-
7.4 Eculizumab Market Concentration Rate of Raw Materials
-
7.5 Eculizumab Cost Structure Analysis
-
7.5.1 Eculizumab Raw Materials Analysis
-
7.5.2 Eculizumab Labor Cost Analysis
-
7.5.3 Eculizumab Manufacturing Expenses Analysis
8 Global Eculizumab Import and Export Analysis (Top 10 Countries)
-
8.1 Global Eculizumab Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Eculizumab Export by Region (Top 10 Countries) (2017-2028)
9 Global Eculizumab Market Outlook by Types and Applications to 2022
-
9.1 Global Eculizumab Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Plasma Exchange Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Plasma Infusion Consumption and Growth Rate (2017-2022)
-
9.2 Global Eculizumab Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global PNH Consumption and Growth Rate (2017-2022)
-
9.2.2 Global aHUS Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Eculizumab Market Analysis and Outlook till 2022
-
10.1 Global Eculizumab Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Eculizumab Consumption (2017-2022)
-
10.2.2 Canada Eculizumab Consumption (2017-2022)
-
10.2.3 Mexico Eculizumab Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Eculizumab Consumption (2017-2022)
-
10.3.2 UK Eculizumab Consumption (2017-2022)
-
10.3.3 Spain Eculizumab Consumption (2017-2022)
-
10.3.4 Belgium Eculizumab Consumption (2017-2022)
-
10.3.5 France Eculizumab Consumption (2017-2022)
-
10.3.6 Italy Eculizumab Consumption (2017-2022)
-
10.3.7 Denmark Eculizumab Consumption (2017-2022)
-
10.3.8 Finland Eculizumab Consumption (2017-2022)
-
10.3.9 Norway Eculizumab Consumption (2017-2022)
-
10.3.10 Sweden Eculizumab Consumption (2017-2022)
-
10.3.11 Poland Eculizumab Consumption (2017-2022)
-
10.3.12 Russia Eculizumab Consumption (2017-2022)
-
10.3.13 Turkey Eculizumab Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Eculizumab Consumption (2017-2022)
-
10.4.2 Japan Eculizumab Consumption (2017-2022)
-
10.4.3 India Eculizumab Consumption (2017-2022)
-
10.4.4 South Korea Eculizumab Consumption (2017-2022)
-
10.4.5 Pakistan Eculizumab Consumption (2017-2022)
-
10.4.6 Bangladesh Eculizumab Consumption (2017-2022)
-
10.4.7 Indonesia Eculizumab Consumption (2017-2022)
-
10.4.8 Thailand Eculizumab Consumption (2017-2022)
-
10.4.9 Singapore Eculizumab Consumption (2017-2022)
-
10.4.10 Malaysia Eculizumab Consumption (2017-2022)
-
10.4.11 Philippines Eculizumab Consumption (2017-2022)
-
10.4.12 Vietnam Eculizumab Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Eculizumab Consumption (2017-2022)
-
10.5.2 Colombia Eculizumab Consumption (2017-2022)
-
10.5.3 Chile Eculizumab Consumption (2017-2022)
-
10.5.4 Argentina Eculizumab Consumption (2017-2022)
-
10.5.5 Venezuela Eculizumab Consumption (2017-2022)
-
10.5.6 Peru Eculizumab Consumption (2017-2022)
-
10.5.7 Puerto Rico Eculizumab Consumption (2017-2022)
-
10.5.8 Ecuador Eculizumab Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Eculizumab Consumption (2017-2022)
-
10.6.2 Kuwait Eculizumab Consumption (2017-2022)
-
10.6.3 Oman Eculizumab Consumption (2017-2022)
-
10.6.4 Qatar Eculizumab Consumption (2017-2022)
-
10.6.5 Saudi Arabia Eculizumab Consumption (2017-2022)
-
10.6.6 United Arab Emirates Eculizumab Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Eculizumab Consumption (2017-2022)
-
10.7.2 South Africa Eculizumab Consumption (2017-2022)
-
10.7.3 Egypt Eculizumab Consumption (2017-2022)
-
10.7.4 Algeria Eculizumab Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Eculizumab Consumption (2017-2022)
-
10.8.2 New Zealand Eculizumab Consumption (2017-2022)
11 Global Eculizumab Competitive Analysis
-
11.1 Alexion
-
11.1.1 Alexion Company Details
-
11.1.2 Alexion Eculizumab Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Alexion Eculizumab Main Business and Markets Served
-
11.1.4 Alexion Eculizumab Product Portfolio
-
11.1.5 Recent Research and Development Strategies
12 Global Eculizumab Market Outlook by Types and Applications to 2028
-
12.1 Global Eculizumab Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Plasma Exchange Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Plasma Infusion Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Eculizumab Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global PNH Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global aHUS Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Eculizumab Market Analysis and Outlook to 2028
-
13.1 Global Eculizumab Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Eculizumab Consumption Forecast (2022-2028)
-
13.2.2 Canada Eculizumab Consumption Forecast (2022-2028)
-
13.2.3 Mexico Eculizumab Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Eculizumab Consumption Forecast (2022-2028)
-
13.3.2 UK Eculizumab Consumption Forecast (2022-2028)
-
13.3.3 Spain Eculizumab Consumption Forecast (2022-2028)
-
13.3.4 Belgium Eculizumab Consumption Forecast (2022-2028)
-
13.3.5 France Eculizumab Consumption Forecast (2022-2028)
-
13.3.6 Italy Eculizumab Consumption Forecast (2022-2028)
-
13.3.7 Denmark Eculizumab Consumption Forecast (2022-2028)
-
13.3.8 Finland Eculizumab Consumption Forecast (2022-2028)
-
13.3.9 Norway Eculizumab Consumption Forecast (2022-2028)
-
13.3.10 Sweden Eculizumab Consumption Forecast (2022-2028)
-
13.3.11 Poland Eculizumab Consumption Forecast (2022-2028)
-
13.3.12 Russia Eculizumab Consumption Forecast (2022-2028)
-
13.3.13 Turkey Eculizumab Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Eculizumab Consumption Forecast (2022-2028)
-
13.4.2 Japan Eculizumab Consumption Forecast (2022-2028)
-
13.4.3 India Eculizumab Consumption Forecast (2022-2028)
-
13.4.4 South Korea Eculizumab Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Eculizumab Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Eculizumab Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Eculizumab Consumption Forecast (2022-2028)
-
13.4.8 Thailand Eculizumab Consumption Forecast (2022-2028)
-
13.4.9 Singapore Eculizumab Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Eculizumab Consumption Forecast (2022-2028)
-
13.4.11 Philippines Eculizumab Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Eculizumab Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Eculizumab Consumption Forecast (2022-2028)
-
13.5.2 Colombia Eculizumab Consumption Forecast (2022-2028)
-
13.5.3 Chile Eculizumab Consumption Forecast (2022-2028)
-
13.5.4 Argentina Eculizumab Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Eculizumab Consumption Forecast (2022-2028)
-
13.5.6 Peru Eculizumab Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Eculizumab Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Eculizumab Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Eculizumab Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Eculizumab Consumption Forecast (2022-2028)
-
13.6.3 Oman Eculizumab Consumption Forecast (2022-2028)
-
13.6.4 Qatar Eculizumab Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Eculizumab Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Eculizumab Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Eculizumab Consumption Forecast (2022-2028)
-
13.7.2 South Africa Eculizumab Consumption Forecast (2022-2028)
-
13.7.3 Egypt Eculizumab Consumption Forecast (2022-2028)
-
13.7.4 Algeria Eculizumab Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Eculizumab Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Eculizumab Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Eculizumab
-
Figure of Eculizumab Picture
-
Table Global Eculizumab Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Eculizumab Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Plasma Exchange Consumption and Growth Rate (2017-2022)
-
Figure Global Plasma Infusion Consumption and Growth Rate (2017-2022)
-
Figure Global PNH Consumption and Growth Rate (2017-2022)
-
Figure Global aHUS Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Eculizumab Consumption by Country (2017-2022)
-
Table North America Eculizumab Consumption by Country (2017-2022)
-
Figure United States Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Canada Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Mexico Eculizumab Consumption and Growth Rate (2017-2022)
-
Table Europe Eculizumab Consumption by Country (2017-2022)
-
Figure Germany Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure UK Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Spain Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Belgium Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure France Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Italy Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Denmark Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Finland Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Norway Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Sweden Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Poland Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Russia Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Turkey Eculizumab Consumption and Growth Rate (2017-2022)
-
Table APAC Eculizumab Consumption by Country (2017-2022)
-
Figure China Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Japan Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure India Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure South Korea Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Thailand Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Singapore Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Philippines Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Eculizumab Consumption and Growth Rate (2017-2022)
-
Table South America Eculizumab Consumption by Country (2017-2022)
-
Figure Brazil Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Colombia Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Chile Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Argentina Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Peru Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Eculizumab Consumption and Growth Rate (2017-2022)
-
Table GCC Eculizumab Consumption by Country (2017-2022)
-
Figure Bahrain Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Oman Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Qatar Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Eculizumab Consumption and Growth Rate (2017-2022)
-
Table Africa Eculizumab Consumption by Country (2017-2022)
-
Figure Nigeria Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure South Africa Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Egypt Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure Algeria Eculizumab Consumption and Growth Rate (2017-2022)
-
Table Oceania Eculizumab Consumption by Country (2017-2022)
-
Figure Australia Eculizumab Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Eculizumab Consumption and Growth Rate (2017-2022)
-
Table Alexion Company Details
-
Table Alexion Eculizumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alexion Eculizumab Main Business and Markets Served
-
Table Alexion Eculizumab Product Portfolio
-
Figure Global Plasma Exchange Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Plasma Infusion Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PNH Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global aHUS Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Eculizumab Consumption Forecast by Country (2022-2028)
-
Table North America Eculizumab Consumption Forecast by Country (2022-2028)
-
Figure United States Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Eculizumab Consumption Forecast by Country (2022-2028)
-
Figure Germany Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Eculizumab Consumption Forecast by Country (2022-2028)
-
Figure China Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Eculizumab Consumption Forecast by Country (2022-2028)
-
Figure Brazil Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Eculizumab Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Eculizumab Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Eculizumab Consumption Forecast by Country (2022-2028)
-
Figure Australia Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Eculizumab Consumption Forecast and Growth Rate (2022-2028)
-
